eVusheld Assessment reaL wORld Effectiveness in DoD Health System

Completed

Conditions studied: COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease

In brief

An AstraZeneca-sponsored observational, electronic healthcare record (EHR)-embedded retrospective cohort study to assess the real-world effectiveness of EVUSHELD against SARS-CoV-2 infection, COVID-19-related hospitalization, and other COVID-19 related outcomes in the total EUA-eligible patient population treated in DoD Health system.

Key facts

Study ID

NCT05569408

Run by

AstraZeneca

People needed

4724

Starts

2023-08-10

Expected to finish

2023-12-22

Last updated by the study team

2024-09-19

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Receipt of Evusheld under the FDA EUA for Evusheld
• Eligibility for Evusheld use under the EUA. -

You may not qualify if…

• None

Where it is running

• Research Site — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.